Sponsor:
Western Michigan University School of Medicine
Code:
NCT04382859
Conditions
Pain, Postoperative
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Accepted
Interventions
Transversus abdominis plane (TAP) block with liposomal bupivacaine
Brief summary:
Conditions
Pain, Postoperative
Study ID
NCT04382859
Start date
Dec 1, 2020
Status verified date
Nov, 2020
Completion date
Feb, 2021
Anticipated
Primary completion date
Dec, 2020
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Accepted
Enrollment
56 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
active comparator: TAP block with liposomal bupivacaine
other: TAP block with 0.25% bupivacaine
Interventions
Transversus abdominis plane (TAP) block with liposomal bupivacaine
Primary outcome measure
Central contacts
Locations
Bronson Methodist Hospital
Recruiting
Kalamazoo, Michigan, United States, 49007
Contacts
Sponsor
Western Michigan University School of Medicine
Last update posted
Nov 27, 2020
Last verified
Nov, 2020
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Western Michigan University School of Medicine on 2020-11-27.